PHARMACIST STEVE

COLUMBUS – Ohio’s opioid epidemic continued to evolve in 2016 with stronger drugs driving an increase in unintentional overdose deaths, according to a new report released by the Ohio Department of Health.

The report showed a sharp rise in overdose deaths involving the opioid fentanyl, the emergence of more deadly fentanyl-related drugs like carfentanil, and indications that cocaine is now being used with fentanyl and other opiates.

Overdose deaths increased from 3,050 in 2015 to 4,050 last year, and fentanyl and related drugs were involved in 58.2 percent of them. By comparison, fentanyl was involved in 37.9 percent of overdose deaths in 2015, 19.9 percent in 2014, 4 percent in 2013 and 3.9 percent 2012.

Illegally produced fentanyl can be hundreds of times stronger than heroin, and carfentanil and other related drugs can be even stronger.

With the emergence of carfentanil in 2016, the fentanyl-related drug was involved in 340 overdose deaths — most of them during the second half of the year. The number of cocaine-related overdose deaths increased from 685 in 2015 to 1,109 in 2016 – a 61.9 percent increase. Of cocaine-related overdose deaths, 80.2 percent also involved an opiate, and 55.8 percent involved fentanyl and related opiates in particular.

Of all unintentional drug overdose deaths, the percentage of prescription opioid-related deaths declined for the fifth straight year in 2016, and the number of such deaths declined 15.4 percent from 667 in 2015 to 564 in 2016, the fewest since 2009. Opioid prescribing in Ohio declined for a fourth consecutive year in 2016, according to the State of Ohio Board of Pharmacy. Between 2012 and 2016, the total number of opioids dispensed to Ohio patients decreased by 162 million doses or 20.4 percent. There was a 78.2 percent decrease in the number of people engaged in the practice of “doctor shopping” for controlled substances since 2012.

The report also contains some promising news – the fewest prescription opioid overdose deaths since 2009.

“The continued increase in opioid-related deaths reaffirms that we still have much work to do, but Ohio is seeing important progress in reducing the number of prescription opioids available for abuse and prescription-related overdose deaths,” said Dr. Mark Hurst, medical director of the Ohio Department of Mental Health and Addiction Services and interim medical director of ODH, in a press release. “This progress is significant because prescription opioid abuse is frequently a gateway to heroin and fentanyl use later on.”